CYTOO's News
Join us on LinkedIn
Discover our latest articles

Imaging mitochondria without artifacts? 🔋
Staining and imaging the highly connected mitochondrial network is difficult, and artifacts are common.
At CYTOO, we have the

Myoscreen – Why do 90% of muscle disease drugs fail in clinical trials? 🤔
The answer: Traditional cell cultures create random, immature muscle cells that don’t mimic real human muscle.

🔬 Turn Your Cell Images Into Powerful Therapeutic Insights with AI-Powered Phenotyping
Behind every microscopy image lies a wealth of information about cellular treatment response.

🔬 Monitoring lipid accumulation in muscle cells with imaging
An imaging-based approach to monitor fatty acid uptake and lipid accumulation in vitro provides spatially resolved, quantitative, and dynamic data

🚀 Powering Precision: Functional Potency Assays by CYTOO
CYTOO develops functional potency assays to ensure batch consistency, biological activity, and regulatory compliance for gene therapies and biologics.

Revolutionizing Target Validation with Disease-Relevant Cellular Models
What’s the risk of using cellular models that lack disease-specific pathways for target validation❓